Genotype-guided warfarin therapy: current status
Data
2018
Autores
Santos, Paulo C. J. L. 
Tipo
Revisão
Título da Revista
ISSN da Revista
Título de Volume
Resumo
Warfarin pharmacogenomics has been an extensively studied field in the last decades as it is focused on personalized therapy to overcome the wide interpatient warfarin response variability and decrease the risk of side effects. In this expert review, besides briefly summarizing the current knowledge about warfarin pharmacogenetics, we also present an overview of recent studies that aimed to assess the efficacy, safety and economic issues related to genotype-based dosing algorithms used to guide warfarin therapy, including randomized and controlled clinical trials, meta-analyses and cost-effectiveness studies. To date, the findings still present disparities, mostly because of standard limitations. Thus, further studies should be encouraged to try to demonstrate the benefits of the application of warfarin pharmacogenomic dosing algorithms in clinical practice.
Descrição
Citação
Pharmacogenomics. London, v. 19, n. 7, p. 667-685, 2018.